1887

Abstract

Although they lack a cell wall, mycoplasmas do possess a glycocalyx. The interactions between the glycocalyx, mycoplasmal surface proteins and host complement were explored using the murine pathogen as a model. It was previously shown that the length of the tandem repeat region of the surface lipoprotein Vsa is associated with susceptibility to complement-mediated killing. Cells producing a long Vsa containing about 40 repeats are resistant to complement, whereas strains that produce a short Vsa of five or fewer repeats are susceptible. We show here that the length of the Vsa protein modulates the affinity of the EPS-I polysaccharide for the mycoplasma cell surface, with more EPS-I being associated with mycoplasmas producing a short Vsa protein. An examination of mutants that lack EPS-I revealed that planktonic mycoplasmas were highly susceptible to complement killing even when the Vsa protein was long, demonstrating that both EPS-I and Vsa length contribute to resistance. In contrast, the mycoplasmas were resistant to complement even in the absence of EPS-I when the cells were encased in a biofilm.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.058222-0
2012-07-01
2020-10-01
Loading full text...

Full text loading...

/deliver/fulltext/micro/158/7/1867.html?itemId=/content/journal/micro/10.1099/mic.0.058222-0&mimeType=html&fmt=ahah

References

  1. Alitalo A., Meri T., Rämö L., Jokiranta T. S., Heikkilä T., Seppälä I. J. T., Oksi J., Viljanen M., Meri S.. ( 2001;). Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun69:3685–3691 [CrossRef][PubMed]
    [Google Scholar]
  2. Bhugra B., Voelker L. L., Zou N., Yu H., Dybvig K.. ( 1995;). Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol Microbiol18:703–714 [CrossRef][PubMed]
    [Google Scholar]
  3. Comstock L. E., Kasper D. L.. ( 2006;). Bacterial glycans: key mediators of diverse host immune responses. Cell126:847–850 [CrossRef][PubMed]
    [Google Scholar]
  4. Daubenspeck J. M., Bolland J. R., Luo W., Simmons W. L., Dybvig K.. ( 2009;). Identification of exopolysaccharide-deficient mutants of Mycoplasma pulmonis. Mol Microbiol72:1235–1245 [CrossRef][PubMed]
    [Google Scholar]
  5. Denison A. M., Clapper B., Dybvig K.. ( 2005;). Avoidance of the host immune system through phase variation in Mycoplasma pulmonis. Infect Immun73:2033–2039 [CrossRef][PubMed]
    [Google Scholar]
  6. Dybvig K., Gasparich G. E., King K. W.. ( 1995;). Artificial transformation of mollicutes via polyethylene glycol- and electroporation-mediated methods. Molecular and Diagnostic Procedures in Mycoplasmology179–184 Razin S., Tully J. G.. Orlando, FL: Academic Press; [CrossRef]
    [Google Scholar]
  7. Dybvig K., French C. T., Voelker L. L.. ( 2000;). Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis. J Bacteriol182:4343–4347 [CrossRef][PubMed]
    [Google Scholar]
  8. French C. T., Lao P., Loraine A. E., Matthews B. T., Yu H., Dybvig K.. ( 2008;). Large-scale transposon mutagenesis of Mycoplasma pulmonis. Mol Microbiol69:67–76 [CrossRef][PubMed]
    [Google Scholar]
  9. Gumulak-Smith J., Teachman A., Tu A.-H. T., Simecka J. W., Lindsey J. R., Dybvig K.. ( 2001;). Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats. Mol Microbiol40:1037–1044 [CrossRef][PubMed]
    [Google Scholar]
  10. Keo T., Collins J., Kunwar P., Blaser M. J., Iovine N. M.. ( 2011;). Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence2:30–40 [CrossRef][PubMed]
    [Google Scholar]
  11. Lindsey J. R., Baker H. J., Overcash R. G., Cassell G. H., Hunt C. E.. ( 1971;). Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol64:675–708[PubMed]
    [Google Scholar]
  12. O’Riordan K., Lee J. C.. ( 2004;). Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev17:218–234 [CrossRef][PubMed]
    [Google Scholar]
  13. Razin S.. ( 1999;). Adherence of pathogenic mycoplasmas to host cells. Biosci Rep19:367–372 [CrossRef][PubMed]
    [Google Scholar]
  14. Razin S., Yogev D., Naot Y.. ( 1998;). Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev62:1094–1156[PubMed]
    [Google Scholar]
  15. Rother K., Till G. O., Hansch G. M.. ( 1997;). The Complement System New York: Springer;
    [Google Scholar]
  16. Shen X., Gumulak J., Yu H., French C. T., Zou N., Dybvig K.. ( 2000;). Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J Bacteriol182:2900–2908 [CrossRef][PubMed]
    [Google Scholar]
  17. Simmons W. L., Dybvig K.. ( 2003;). The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene. Infect Immun71:5733–5738 [CrossRef][PubMed]
    [Google Scholar]
  18. Simmons W. L., Dybvig K.. ( 2007;). Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin. Infect Immun75:3696–3699 [CrossRef][PubMed]
    [Google Scholar]
  19. Simmons W. L., Zuhua C., Glass J. I., Simecka J. W., Cassell G. H., Watson H. L.. ( 1996;). Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation. Infect Immun64:472–479[PubMed]
    [Google Scholar]
  20. Simmons W. L., Denison A. M., Dybvig K.. ( 2004;). Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis. Infect Immun72:6846–6851 [CrossRef][PubMed]
    [Google Scholar]
  21. Simmons W. L., Bolland J. R., Daubenspeck J. M., Dybvig K.. ( 2007;). A stochastic mechanism for biofilm formation by Mycoplasma pulmonis. J Bacteriol189:1905–1913 [CrossRef][PubMed]
    [Google Scholar]
  22. Taylor-Robinson D., Schorlemmer H. U., Furr P. M., Allison A. C.. ( 1978;). Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms. Clin Exp Immunol33:486–494[PubMed]
    [Google Scholar]
  23. Yus E., Maier T., Michalodimitrakis K., van Noort V., Yamada T., Chen W. H., Wodke J. A., Güell M., Martínez S.. & other authors ( 2009;). Impact of genome reduction on bacterial metabolism and its regulation. Science326:1263–1268 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.058222-0
Loading
/content/journal/micro/10.1099/mic.0.058222-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error